APA (7th ed.) Citation

Sasaki, M., Ueno, H., Mitsunaga, S., Ohba, A., Hosoi, H., Kobayashi, S., . . . Okusaka, T. (2021). A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer. International Journal of Clinical Oncology, 26(11), 2065-2072. https://doi.org/10.1007/s10147-021-02001-y

Chicago Style (17th ed.) Citation

Sasaki, Mitsuhito, et al. "A Phase II Study of FOLFIRINOX with Primary Prophylactic Pegfilgrastim for Chemotherapy-naïve Japanese Patients with Metastatic Pancreatic Cancer." International Journal of Clinical Oncology 26, no. 11 (2021): 2065-2072. https://doi.org/10.1007/s10147-021-02001-y.

MLA (9th ed.) Citation

Sasaki, Mitsuhito, et al. "A Phase II Study of FOLFIRINOX with Primary Prophylactic Pegfilgrastim for Chemotherapy-naïve Japanese Patients with Metastatic Pancreatic Cancer." International Journal of Clinical Oncology, vol. 26, no. 11, 2021, pp. 2065-2072, https://doi.org/10.1007/s10147-021-02001-y.